Dore GJ - Search Results

1

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.

Preiss S, Littlejohn M, Angus P, Thompson A, Desmond P, Lewin SR, Sasadeusz J, Matthews G, Dore GJ, Shaw T, Sozzi V, Yuen L, Lau G, Ayres A, Thio C, Avihingsanon A, Ruxrungtham K, Locarnini S, Revill PA. Preiss S, et al. Among authors: dore gj. Hepatology. 2008 Sep;48(3):741-9. doi: 10.1002/hep.22386. Hepatology. 2008. PMID: 18571815 Free PMC article.

2

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM. Freeman AJ, et al. Among authors: dore gj. Hepatology. 2001 Oct;34(4 Pt 1):809-16. doi: 10.1053/jhep.2001.27831. Hepatology. 2001. PMID: 11584380

3

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001.

Law WP, Dore GJ, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA. Law WP, et al. Among authors: dore gj. AIDS. 2003 Oct 17;17(15):2191-9. doi: 10.1097/00002030-200310170-00007. AIDS. 2003. PMID: 14523276

4

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ. Law WP, et al. Among authors: dore gj. AIDS. 2004 May 21;18(8):1169-77. doi: 10.1097/00002030-200405210-00010. AIDS. 2004. PMID: 15166532 Clinical Trial.

5

Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children.

Rerksuppaphol S, Hardikar W, Dore GJ. Rerksuppaphol S, et al. Among authors: dore gj. J Gastroenterol Hepatol. 2004 Dec;19(12):1357-62. doi: 10.1111/j.1440-1746.2004.03463.x. J Gastroenterol Hepatol. 2004. PMID: 15610308 Review.

6

Treatment for hepatitis C virus infection among current injection drug users in Australia.

Matthews G, Kronborg IJ, Dore GJ. Matthews G, et al. Among authors: dore gj. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S325-9. doi: 10.1086/427448. Clin Infect Dis. 2005. PMID: 15768342 Review.

7

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.

Matthews GV, Bartholomeusz A, Locarnini S, Ayres A, Sasaduesz J, Seaberg E, Cooper DA, Lewin S, Dore GJ, Thio CL. Matthews GV, et al. Among authors: dore gj. AIDS. 2006 Apr 4;20(6):863-70. doi: 10.1097/01.aids.0000218550.85081.59. AIDS. 2006. PMID: 16549970

8

Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.

Matthews GV, Dore GJ. Matthews GV, et al. Among authors: dore gj. AIDS. 2007 Mar 30;21(6):777-8. doi: 10.1097/QAD.0b013e3280b07774. AIDS. 2007. PMID: 17413705 No abstract available.

9

Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.

Matthews GV, Cooper DA, Dore GJ. Matthews GV, et al. Among authors: dore gj. Antivir Ther. 2007;12(1):119-22. Antivir Ther. 2007. PMID: 17503756

10

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.

Revill PA, Littlejohn M, Ayres A, Yuen L, Colledge D, Bartholomeusz A, Sasaduesz J, Lewin SR, Dore GJ, Matthews GV, Thio CL, Locarnini SA. Revill PA, et al. Among authors: dore gj. AIDS. 2007 Aug 20;21(13):1701-10. doi: 10.1097/QAD.0b013e32826fb305. AIDS. 2007. PMID: 17690567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters